文献速递妇科

绝经后出血女性经宫腔镜子宫内膜切除治疗的151例组织病理学与临床结局

Histopathology and Clinical Outcomes of 151 Women with Postmenopausal Bleeding Treated with Resectoscopic Surgery.
PubMed 文献 · J Minim Invasive Gynecol · 2019-06-13

回顾性队列纳入1990年9月至2010年12月共151例绝经后出血女性,在手术室行宫腔镜子宫内膜切除(HER)。中位随访11.5年时132例(87.4%)无再出血且满意,HER可诊断全部病例并治疗多数宫内病变,包括非典型子宫内膜增生及选择性非典型增生和子宫内膜癌病例。

要点

  • 诊室子宫内膜活检失败30例(19.8%)、取材不足20例(13.2%)。
  • HER新发现非典型增生7例、子宫内膜癌9例。
  • 中位随访11.5年,132例(87.4%)无再出血且满意。

核心结论

  • 在绝经后出血女性中,由经验丰富术者行宫腔镜子宫内膜切除并同时切除宫内病变,对所有病例诊断可行、安全、有效,且对多数宫内病变(包括非典型子宫内膜增生及选择性非典型增生和子宫内膜癌病例)治疗有效。

研究设计与样本

  • 回顾性队列研究,纳入1990年9月至2010年12月一所大学附属教学医院的151例绝经后出血女性,干预为在手术室行宫腔镜子宫内膜切除。

主要发现

  • 诊室子宫内膜活检失败30例(19.8%)、取材不足20例(13.2%)、非典型子宫内膜增生21例(14%)、非典型增生4例(2.6%)、子宫内膜癌2例(1.3%)。
  • HER在151例中新发现非典型增生7例(3例来自活检失败或取材不足,4例来自非典型子宫内膜增生)和子宫内膜癌9例(5例来自活检失败或取材不足,1例来自增殖期内膜,2例来自非典型子宫内膜增生,1例来自非典型增生)。
  • 27例非典型子宫内膜增生均仅以HER治疗;8例非典型增生中6例行HER、2例行子宫切除,子宫切除标本未见残留内膜;11例子宫内膜癌中2例拒绝子宫切除,HER后10年和15年状况良好。
  • 11例子宫内膜癌中9例行子宫切除,8例非典型增生中2例行子宫切除,1例因异常子宫出血行子宫切除;6例因持续异常子宫出血行重复HER,10例失访。
  • 中位随访11.5年(范围7-20年),151例中132例(87.4%,含12例子宫切除和10例失访)无再出血且满意。

临床怎么用

  • 作者认为,对绝经后出血女性,由经验丰富术者行宫腔镜子宫内膜切除并同时切除宫内病变,对所有病例诊断可行、安全、有效,且对多数宫内病变包括非典型子宫内膜增生及选择性非典型增生和子宫内膜癌病例治疗有效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: Because postmenopausal bleeding (PMB) is associated with up to 10% of endometrial neoplasia and office endometrial sampling fails in approximately 10% and is inadequate in 30% of cases, the objective was to determine the role of hysteroscopic endometrial resection (HER) for the diagnosis and treatment of women with PMB. DESIGN: A retrospective cohort. SETTING: A university-affiliated teaching hospital. PATIENTS: One hundred fifty-one women with PMB (September 1990-December 2010). INTERVENTION: HER in the operating room. MEASUREMENTS AND MAIN RESULTS: The median (range) age and body mass index were 58 (50-87) years and 29 (21-52) kg/m2, respectively. Office endometrial biopsy failed in 30 (19.8%), was inadequate in 20 (13.2%), identified nonatypical endometrial hyperplasia (NAH) in 21 (14%), atypical hyperplasia (AH) in 4 (2.6%), and endometrial cancer (EC) in 2 (1.3%) women. HER in 151 women identified 7 new cases of AH (3 from failed/inadequate office biopsy and 4 from NAH) and 9 EC (5 from failed/inadequate office biopsy, 1 from proliferative endometrium, 2 from NAH, and 1 from AH). All 27 women with NAH were treated by HER alone. Of 8 women with AH, 6 were treated with HER and 2 with hysterectomy; no residual endometrium was found in hysterectomy specimens. Of the 11 women with EC, 2 refused hysterectomy and are well 10 and 15 years after HER. Hysterectomy was performed for 9 of 11 EC cases, 2 of 8 AH cases, and 1 for abnormal uterine bleeding. Six women had repeat HER for persistent abnormal uterine bleeding, and 10 were lost to follow-up. At a median follow-up of 11.5 years (range, 7-20 years), 132 (12 hysterectomies + 10 lost) of 151 (87.4%) women were satisfied with no further bleeding. CONCLUSION: In women with PMB, hysteroscopic endometrial resection concomitantly with resection of intrauterine pathology by experienced surgeons is feasible, safe, and effective for diagnosis in all cases and treatment of the majority of intrauterine pathology including NAH and selected cases of AH and EC.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Vilos GA, AlJasser R, Vilos AG, et al. Histopathology and Clinical Outcomes of 151 Women with Postmenopausal Bleeding Treated with Resectoscopic Surgery. J Minim Invasive Gynecol. 2019. PMID: 31202823. doi:10.1016/j.jmig.2019.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。